Sanofi turns the tables on Lilly with biosimilar fast-acting insulin Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi.

NICE has recommended Alexion’s long-acting Ultomiris (ravulizumab) for the rare disease paroxysmal nocturnal haemoglobinuria (PNH) in final draft guidance. Ultomiris is Alexion’s follow-up to ...

The best long-term dividend stocks can provide steady cash flow and appreciation. Discover some of the top dividend stocks to consider.